Relationships between the five-gene signature risk score and the clinical characteristics of NB patients, including INSS stage, age, MYCN status, tumor histology, tumor ploidy, and race, were analyzed in TARGET data sets. This evidence concerns the gene MYCN and neuroblastoma.